Aclaris Therapeutics, Inc. Uncategorized Contracts & Agreements
8 Contracts & Agreements
- Letter Agreement, dated as of January 31, 2024, by and between the Registrant and Neal Walker (Filed With SEC on February 27, 2024)
- Description of Securities (Filed With SEC on February 27, 2024)
- (a Delaware limited liability company) (a Delaware corporation) Rentable Square Feet First Floor Suite 103 Chesterbrook Corporate Center 701 Lee Road Wayne, Pennsylvania (Filed With SEC on June 1, 2023)
- Letter Agreement, dated as of November 22, 2022, by and between the Registrant and Neal Walker (Filed With SEC on February 23, 2023)
- Description of Securities (Filed With SEC on February 25, 2021)
- Open Market Sale Agreement, dated March 13, 2020, by and between Aclaris Therapeutics, Inc. and Jefferies LLC (Filed With SEC on March 13, 2020)
- Description of Securities (Filed With SEC on February 25, 2020)
- Aclaris Therapeutics, Inc. 2017 Inducement Plan Adopted by the Board of Directors: July 31, 2017 (Filed With SEC on August 1, 2017)
